Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | CA3 | P07451 | 2/20 | 0.43 |
| ▸ | CA5A | P35218 | 2/20 | 0.43 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 4/20 | 0.40 |
| ▸ | CA2 | P00918 | 4/20 | 0.40 |
| ▸ | CA9 | Q16790 | 4/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
| ▸ | CA6 | P23280 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7816788 | 0.88 | CA14 (0.55) | CA14ALDH1A1POLBSMN1; SMN2CA3 | |
| SCHEMBL23568851 | 0.86 | CA14 (0.48) | CA14ALDH1A1POLBSMN1; SMN2CA3 | |
| SCHEMBL3791758 | 0.83 | CA3 (0.59) | CA14ALDH1A1POLBSMN1; SMN2CA3 | |
| SCHEMBL29354354 | 0.83 | MEN1 (0.43) | ALDH1A1MEN1KMT2ATDP1EPHX1 | |
| SCHEMBL20050532 | 0.82 | TDP1 (0.44) | CA14ALDH1A1MEN1KMT2ATDP1 | |
| SCHEMBL16082152 | 0.82 | APLNR (0.44) | CA14ALDH1A1POLBSMN1; SMN2MEN1 | |
| SCHEMBL23465641 | 0.82 | TDP1 (0.44) | CA14ALDH1A1MEN1KMT2ATDP1 | |
| SCHEMBL25327812 | 0.81 | MEN1 (0.47) | CA14ALDH1A1MEN1KMT2ATDP1 | |
| SCHEMBL10243062 | 0.81 | TDP1 (0.46) | CA14ALDH1A1MEN1KMT2ATDP1 | |
| SCHEMBL20045685 | 0.81 | CA14 (0.60) | CA14ALDH1A1POLBSMN1; SMN2CA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12617905-B2 | Crosslinked alginic acid | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2026-05-05 | — | — | US | disclosed |
| US-12312574-B2 | Polymer-coated crosslinked alginate gel fiber | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2025-05-27 | — | — | US | disclosed |
| US-20240342340-A1 | MULTILAYER STRUCTURE USING CHEMICALLY CROSSLINKED ALGINIC ACID | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2024-10-17 | — | — | US | disclosed |
| US-20240174959-A1 | NOVEL POLYMER-COATED CROSSLINKED ALGINATE GEL FIBER | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2024-05-30 | — | — | US | disclosed |
| EP-4361249-A1 | NOVEL POLYMER-COATED CROSSLINKED ALGINATE GEL FIBER | Mochida Pharmaceutical Co., Ltd. (JP) | 2024-05-01 | — | — | EP | disclosed |
| US-20240132854-A1 | NOVEL MULTILAYER POLYMER-COATED CROSSLINKED ALGINATE GEL FIBER | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2024-04-25 | — | — | US | disclosed |
| EP-4268857-A1 | NOVEL MULTILAYER POLYMER-COATED CROSSLINKED ALGINATE GEL FIBER | Mochida Pharmaceutical Co., Ltd. (JP) | 2023-11-01 | — | — | EP | disclosed |
| EP-4268857-A1 | NOVEL MULTILAYER POLYMER-COATED CROSSLINKED ALGINATE GEL FIBER | Mochida Pharmaceutical Co., Ltd. (JP) | 2023-11-01 | — | — | EP | disclosed |
| EP-4268856-A1 | MULTILAYER STRUCTURE USING CHEMICALLY CROSSLINKED ALGINIC ACID | Mochida Pharmaceutical Co., Ltd. (JP) | 2023-11-01 | — | — | EP | disclosed |
| US-20230035986-A1 | NOVEL CROSSLINKED ALGINIC ACID | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2023-02-02 | — | — | US | disclosed |
| US-20230035986-A1 | NOVEL CROSSLINKED ALGINIC ACID | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2023-02-02 | — | — | US | disclosed |
| WO-2022270549-A1 | NOVEL POLYMER-COATED CROSSLINKED ALGINATE GEL FIBER | 持田製薬株式会社 | 2022-12-29 | — | — | WO | disclosed |
| WO-2022270549-A1 | NOVEL POLYMER-COATED CROSSLINKED ALGINATE GEL FIBER | 持田製薬株式会社 | 2022-12-29 | — | — | WO | disclosed |
| WO-2022145419-A1 | MULTILAYER STRUCTURE USING CHEMICALLY CROSSLINKED ALGINIC ACID | 持田製薬株式会社 | 2022-07-07 | — | — | WO | disclosed |
| WO-2022145420-A1 | NOVEL MULTILAYER POLYMER-COATED CROSSLINKED ALGINATE GEL FIBER | 持田製薬株式会社 | 2022-07-07 | — | — | WO | disclosed |
| WO-2021125255-A1 | NOVEL CROSSLINKED ALGINIC ACID | 持田製薬株式会社 | 2021-06-24 | — | — | WO | disclosed |
| WO-2021125279-A1 | CHEMICALLY CROSSLINKED ALGINATE GEL FIBER | 持田製薬株式会社 | 2021-06-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12617905-B2 | Crosslinked alginic acid | ALG1, ANXA6, HEXB | CA14 1481/4885ALDH1A1 469/4885POLB 789/4885 |
| US-20240132854-A1 | NOVEL MULTILAYER POLYMER-COATED CROSSLINKED ALGINATE GEL FIBER | IAPP, COG6, IL6 | CA14 221/4885ALDH1A1 4206/4885POLB 4007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.